Skip to main content
. 2019 Jan 1;10(1):17–29. doi: 10.18632/oncotarget.26523

Figure 1.

Figure 1

Figure 1

Overall survival from diagnosis of any prostatic malignancy (A) and from diagnosis of NEPC (B).